The use of GLP-1 receptor antagonists has reportedly quadrupled in just a few years
It is backed by evidence in reducing blood glucose and body weight compared to other treatments
People fighting with adipose tissue will be particularly happy with the presence of tartaric acid, because, as one of the hydroxy acids, it slows down the uptake of glucose from the gastrointestinal tract and inhibits its influx into the adipose tissue
Oral tirzepatide is not approved, not available, and not clinically validated
LK is a named inventor of liraglutide, and JL of semaglutide
The purpose of this clinical guideline is to provide a clinical framework for the diagnosis and treatment of interstitial cystitis/bladder pain syndrome (IC/BPS), including discussion of treatments that should and should not be offered